Additionally, western blotting revealed that EP4 receptor activation improved the reduced SPC levels induced by BLM, suggesting protection against the loss and damage of AECII in BLM-induced pulmonary fibrosis mice (Figure 7H-I). The gene discussed is SFTPC; the disease is pulmonary fibrosis.